Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.04 | 0.5 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.22 | 0.5 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |